1. Home
  2. ANGH vs MAIA Comparison

ANGH vs MAIA Comparison

Compare ANGH & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANGH
  • MAIA
  • Stock Information
  • Founded
  • ANGH 2012
  • MAIA 2018
  • Country
  • ANGH United Arab Emirates
  • MAIA United States
  • Employees
  • ANGH N/A
  • MAIA N/A
  • Industry
  • ANGH Telecommunications Equipment
  • MAIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANGH Consumer Discretionary
  • MAIA Health Care
  • Exchange
  • ANGH Nasdaq
  • MAIA Nasdaq
  • Market Cap
  • ANGH 52.2M
  • MAIA 52.8M
  • IPO Year
  • ANGH N/A
  • MAIA 2022
  • Fundamental
  • Price
  • ANGH $0.70
  • MAIA $2.00
  • Analyst Decision
  • ANGH
  • MAIA
  • Analyst Count
  • ANGH 0
  • MAIA 0
  • Target Price
  • ANGH N/A
  • MAIA N/A
  • AVG Volume (30 Days)
  • ANGH 50.9K
  • MAIA 346.7K
  • Earning Date
  • ANGH 01-24-2025
  • MAIA 11-12-2024
  • Dividend Yield
  • ANGH N/A
  • MAIA N/A
  • EPS Growth
  • ANGH N/A
  • MAIA N/A
  • EPS
  • ANGH N/A
  • MAIA N/A
  • Revenue
  • ANGH $52,274,011.00
  • MAIA N/A
  • Revenue This Year
  • ANGH N/A
  • MAIA N/A
  • Revenue Next Year
  • ANGH N/A
  • MAIA N/A
  • P/E Ratio
  • ANGH N/A
  • MAIA N/A
  • Revenue Growth
  • ANGH 13.03
  • MAIA N/A
  • 52 Week Low
  • ANGH $0.62
  • MAIA $1.17
  • 52 Week High
  • ANGH $2.27
  • MAIA $5.99
  • Technical
  • Relative Strength Index (RSI)
  • ANGH 43.81
  • MAIA 44.72
  • Support Level
  • ANGH $0.62
  • MAIA $1.97
  • Resistance Level
  • ANGH $0.83
  • MAIA $2.44
  • Average True Range (ATR)
  • ANGH 0.06
  • MAIA 0.20
  • MACD
  • ANGH -0.01
  • MAIA 0.00
  • Stochastic Oscillator
  • ANGH 36.36
  • MAIA 8.33

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with the catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner and is continuously licensing new content.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Share on Social Networks: